ES2052019T3 - Espiro-isoquinolein-pirrolidin tetronas y analogos de las mismas, utiles como inhibidores de la aldosa-reductasa. - Google Patents

Espiro-isoquinolein-pirrolidin tetronas y analogos de las mismas, utiles como inhibidores de la aldosa-reductasa.

Info

Publication number
ES2052019T3
ES2052019T3 ES89310762T ES89310762T ES2052019T3 ES 2052019 T3 ES2052019 T3 ES 2052019T3 ES 89310762 T ES89310762 T ES 89310762T ES 89310762 T ES89310762 T ES 89310762T ES 2052019 T3 ES2052019 T3 ES 2052019T3
Authority
ES
Spain
Prior art keywords
espiro
tetronas
aldosa
isoquinolein
reductasa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89310762T
Other languages
English (en)
Inventor
Michael Sotirios Malamas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/357,563 external-priority patent/US4927831A/en
Priority claimed from GB898919736A external-priority patent/GB8919736D0/en
Application filed by American Home Products Corp filed Critical American Home Products Corp
Application granted granted Critical
Publication of ES2052019T3 publication Critical patent/ES2052019T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA INVENCION ES RELATIVA A ESPIRO-ISOQUINOLINA-PIRROLIDINA BUTANONAS Y SUS SALES FARMACEUTICAMENTE ACEPTABLES TENIENDO FORMULA I: Y ANALOGAS A ELLA, EN DONDE EL ANILLO DE BENCENO FUSIONADO ESTA REEMPLAZADO POR UN TRIOFENO FUSIONADO, PIRIDINA, O ANILLO DE FURANO, EN DONDE R1, R2 Y R3 SON INDEPENDIENTEMENTE HIDROGENO O SUSTITUYENTES DEFINIDOS Y M, W, X, Y Y Z TIENEN SIGNIFICADOS DEFINIDOS. TAMBIEN SE PROVEEN PROCESOS PARA PREPARAR LOS COMPUESTOS Y COMPOSICIONES FARMACEUTICAS. LOS COMPUESTOS TIENEN PROPIEDADES FARMACEUTICAS LAS CUALES RESULTAN BENEFICIOSAS PARA LA PREVENCION O TRATAMIENTO DE COMPLICACIONES ASOCIADAS A LA DIABETES.
ES89310762T 1988-10-20 1989-10-19 Espiro-isoquinolein-pirrolidin tetronas y analogos de las mismas, utiles como inhibidores de la aldosa-reductasa. Expired - Lifetime ES2052019T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26043488A 1988-10-20 1988-10-20
US07/357,563 US4927831A (en) 1988-10-20 1989-05-26 Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
GB898919736A GB8919736D0 (en) 1989-08-31 1989-08-31 Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibators

Publications (1)

Publication Number Publication Date
ES2052019T3 true ES2052019T3 (es) 1994-07-01

Family

ID=27264666

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89310762T Expired - Lifetime ES2052019T3 (es) 1988-10-20 1989-10-19 Espiro-isoquinolein-pirrolidin tetronas y analogos de las mismas, utiles como inhibidores de la aldosa-reductasa.

Country Status (7)

Country Link
EP (1) EP0365324B1 (es)
AU (2) AU617541B2 (es)
DE (1) DE68915112T2 (es)
ES (1) ES2052019T3 (es)
GB (2) GB2224734B (es)
HK (1) HK168195A (es)
IE (1) IE64498B1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
GB2252321B (en) * 1988-10-20 1993-02-24 American Home Prod Process for preparing isoquinoline intermediates
US5037831A (en) * 1990-05-21 1991-08-06 American Home Products Corporation Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
US5045544A (en) * 1990-05-21 1991-09-03 American Home Products Corporation N'-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US5102886A (en) * 1990-10-12 1992-04-07 American Home Products Corporation 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
US5169948A (en) * 1991-05-22 1992-12-08 American Home Products Corporation Process and intermediates for the preparation of spiro[isoquinoline-4(1H),3-pyrrolidine]1,2,3,5 (2H)-tetrones which are useful as aldose reductase inhibitors
SG47769A1 (en) * 1991-05-22 1998-04-17 American Home Prod Process and intermediate for making of isoquinoline derivatives
TW202450B (es) * 1991-06-26 1993-03-21 Dainippon Pharmaceutical Co
US6384013B1 (en) 1992-03-19 2002-05-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
KR20020003864A (ko) 1999-03-03 2002-01-15 피터 지. 스트링거 에키노칸딘/탄수화물 착물
ATE294571T1 (de) 1999-03-03 2005-05-15 Lilly Co Eli Echinocandin pharmazeutische zusammensetzungen
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1185934A (en) * 1967-06-28 1970-03-25 Pfizer & Co C Derivatives of 1,3(2H,4H)-Dioxoisoquinoline and preparation thereof
US4210756A (en) * 1976-10-18 1980-07-01 Pfizer Inc. Tetrahydroquinoline hydantoins for chronic diabetic complications
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
ES8400116A1 (es) * 1981-10-13 1983-10-16 Pfizer "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
FR2525603A1 (fr) * 1982-04-27 1983-10-28 Adir Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique
FR2544317B2 (fr) * 1983-04-12 1985-07-05 Adir Benzoazacycloalkyl-spiro-imidazolidines et les compositions pharmaceutiques les contenant
DK277484A (da) * 1983-06-23 1984-12-24 Hoffmann La Roche Thiazolidinderivater
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
GB2252321B (en) * 1988-10-20 1993-02-24 American Home Prod Process for preparing isoquinoline intermediates

Also Published As

Publication number Publication date
EP0365324B1 (en) 1994-05-04
AU617541B2 (en) 1991-11-28
IE893363L (en) 1990-04-20
DE68915112T2 (de) 1994-10-06
GB2224734B (en) 1993-03-03
GB8923622D0 (en) 1989-12-06
GB2257971A (en) 1993-01-27
GB9220822D0 (en) 1992-11-18
GB2224734A (en) 1990-05-16
EP0365324A1 (en) 1990-04-25
IE64498B1 (en) 1995-08-09
AU4298389A (en) 1990-04-26
GB2257971B (en) 1993-04-14
AU1043592A (en) 1992-03-19
AU635873B2 (en) 1993-04-01
DE68915112D1 (de) 1994-06-09
HK168195A (en) 1995-11-10

Similar Documents

Publication Publication Date Title
CO2022015054A2 (es) [1,3]diazino[5,4-d]pirimidinas como inhibidores de her2
CL2022002386A1 (es) Compuestos de amino pirimidina fusionados
ES2011210T3 (es) Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
CR7743A (es) Nuevos compuestos de oxazol y tiazol como inhibidorea del factor de crecimiento transformador (tgf)
UY28695A1 (es) Derivados de difenilazetidona
AR016762A1 (es) Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo
ES2194265T3 (es) Derivados de piperidino 4-carboxamida y su utilizacion como antagonistas de la neuroquinina.
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
CR20230485A (es) Derivados de fósforo como nuevos inhibidores de sos1
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2051772T3 (es) 2-sustituido-e-fusionado-(1,2,4)-triazol(1,5-c)pirimidinas, composiciones farmaceuticas y sus usos.
AR012294A1 (es) Derivados de sulfonamida, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen, uso de dichos derivados para lapreparacion de un medicamento.
AR123685A1 (es) Antagonistas del mrgx2
AR018139A1 (es) Un compuesto n-[3-hidroxi-5[(1,4,5,6-tetrahidro-5-hidroxi-2-pirimidinil)amino]benzoil]glici-3-(3-halo-5-halo-2-hidroxifenil)-beta alanina, composicionfarmaceutica y uso del mismo en la fabricacion de un medicamento.
AR124868A1 (es) Compuestos de heterociclo tetracíclicos útiles como inhibidores de la integrasa del vih
UY40701A (es) Protacs para irak4
AR133953A1 (es) Inhibidores del factor b del complemento y usos de los mismos
PY2201650A (es) Nuevos derivados de espirociclohexano, composiciones farmacéuticas que los contienen y sus usos como inhibidores antiapoptóticos
CO2026002534A2 (es) Compuestos de oxoisoindolinil piperidina-2,6-diona sustituida
ES2101012T3 (es) Derivados de acidos guanidinoalquilo-1,1-bisfosfonicos, procedimiento para su preparacion y su utilizacion.
CL2025002072A1 (es) Inhibidores de prmt5–mta.
CO4130200A1 (es) Inhibidores de proteasa del hiv utiles en el tratamiento del sida
MX2025006719A (es) Análogos de nucleótidos, composiciones y usos de los mismos
ES2054811T3 (es) Derivados de tetrahidroisoquinolin-2-ilo como antagonistas de tromboxano a2.
AR004726A1 (es) Derivados 25-hidroxi-16-eno-26,27-bis homo-colecalciferol, compuestos intermediarios para su preparacion, composiciones farmaceuticas que loscontienen y uso de dichos derivados para fabricar un medicamento.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 365324

Country of ref document: ES